IBOV 171,324.31 ▼ 0.43% IPC MEX 71,674.32 ▼ 0.46% MERVAL 2,848,945 — — USD/BRL5.64▲ 1.06% USD/MXN18.58▼ 0.11% USD/CLP994.00▲ 1.14% USD/COP3,302▼ 0.16% USD/PEN3.41▼ 0.06% USD/ARS1,545▲ 0.03% USD/UYU40.52▲ 3.32% USD/PYG6,185▲ 3.33% USD/BOB11.60▲ 0.86% USD/DOP60.47▲ 0.03% USD/CRC445.25▲ 1.62% USD/GTQ7.65▲ 3.31% USD/HNL26.90▲ 3.30% USD/NIO36.62▲ 2.73% USD/VES909.35▲ 0.67% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.09▲ 2.15% USD/TTD6.71▲ 2.19% EUR/BRL6.24▲ 0.10% BRENT 95.57 ▲ 3.03% WTI 88.44 ▲ 2.21% IRON ORE 161.91 — — COPPER 6.21 ▼ 1.11% GOLD 3,889 ▼ 2.79% SILVER 50.01 ▼ 3.62% SOY 1,220 ▼ 0.77% CORN 442.25 ▼ 1.28% WHEAT 582.50 ▼ 2.84% COFFEE 275.10 ▲ 2.27% SUGAR 18.22 ▼ 1.41% ORANGE JUICE 140.60 ▼ 0.25% COTTON 78.56 ▲ 0.05% COCOA 5,187 ▲ 5.71% BEEF 223.05 ▲ 1.86% CATTLE 331.80 ▼ 0.25% LITHIUM 59.43 ▼ 0.92% PETR4 44.70 ▲ 2.64% VALE3 63.95 ▼ 0.75% ITUB4 41.68 ▼ 0.10% BBDC4 14.32 ▼ 0.07% ABEV3 15.75 ▼ 0.63% BBAS3 15.48 ▼ 8.35% B3SA3 14.76 ▼ 0.27% WEGE3 51.65 ▲ 0.08% PRIO3 63.30 ▲ 2.98% SUZB3 56.04 ▲ 4.16% RENT3 29.58 ▼ 2.18% AZZA3 16.90 ▲ 9.95% CSAN3 2.85 ▼ 5.94% RAIZ4 0.30 ▼ 98.60% PCAR3 2.39 ▼ 5.91% GMAT3 3.84 ▼ 5.88% PSSA3 45.94 ▼ 0.09% CVCB3 0.84 ▼ 2.33% POSI3 3.37 ▲ 1.51% SLCE3 18.36 ▲ 7.68% NATU3 5.33 ▼ 5.16% BRKM5 3.07 ▲ 5.14% RANI3 8.18 ▼ 2.50% CSNA3 4.23 ▼ 6.42% IBOV 171,324.31 ▼ 0.43% IPC MEX 71,674.32 ▼ 0.46% MERVAL 2,848,945 — — USD/BRL 5.64 ▲ 1.06% USD/MXN 18.58 ▼ 0.09% USD/CLP 994.00 ▲ 1.14% USD/COP 3,302 ▼ 0.16% USD/PEN 3.41 ▼ 0.06% USD/ARS 1,545 ▲ 0.03% USD/UYU 40.52 ▲ 3.32% USD/PYG 6,185 ▲ 3.33% USD/BOB 11.60 ▲ 0.86% USD/DOP 60.47 ▲ 0.03% USD/CRC 445.25 ▲ 1.62% USD/GTQ 7.65 ▲ 3.31% USD/HNL 26.90 ▲ 3.30% USD/NIO 36.62 ▲ 2.73% USD/VES 909.35 ▲ 0.67% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.09 ▲ 1.00% USD/TTD 6.71 ▲ 1.04% EUR/BRL 6.24 ▲ 0.11% BRENT 95.57 ▲ 3.03% WTI 88.44 ▲ 2.21% IRON ORE 161.91 — — COPPER 6.21 ▼ 1.11% GOLD 3,889 ▼ 2.79% SILVER 50.01 ▼ 3.62% SOY 1,220 ▼ 0.77% CORN 442.25 ▼ 1.28% WHEAT 582.50 ▼ 2.84% COFFEE 275.10 ▲ 2.27% SUGAR 18.22 ▼ 1.41% ORANGE JUICE 140.60 ▼ 0.25% COTTON 78.56 ▲ 0.05% COCOA 5,187 ▲ 5.71% BEEF 223.05 ▲ 1.86% CATTLE 331.80 ▼ 0.25% LITHIUM 59.43 ▼ 0.92% PETR4 44.70 ▲ 2.64% VALE3 63.95 ▼ 0.75% ITUB4 41.68 ▼ 0.10% BBDC4 14.32 ▼ 0.07% ABEV3 15.75 ▼ 0.63% BBAS3 15.48 ▼ 8.35% B3SA3 14.76 ▼ 0.27% WEGE3 51.65 ▲ 0.08% PRIO3 63.30 ▲ 2.98% SUZB3 56.04 ▲ 4.16% RENT3 29.58 ▼ 2.18% AZZA3 16.90 ▲ 9.95% CSAN3 2.85 ▼ 5.94% RAIZ4 0.30 ▼ 98.60% PCAR3 2.39 ▼ 5.91% GMAT3 3.84 ▼ 5.88% PSSA3 45.94 ▼ 0.09% CVCB3 0.84 ▼ 2.33% POSI3 3.37 ▲ 1.51% SLCE3 18.36 ▲ 7.68% NATU3 5.33 ▼ 5.16% BRKM5 3.07 ▲ 5.14% RANI3 8.18 ▼ 2.50% CSNA3 4.23 ▼ 6.42%
since 2009
Friday, November 13, 2026

Viagra May Be Key for Treating Leukemia and Lymphoma

By · · 2 min read

RIO DE JANEIRO, BRAZIL – Researchers at the University of California in the United States have found in a new study that Viagra can be useful for purposes other than erectile dysfunction: the drug could be used in bone marrow transplants.

The experiment, which could potentially be groundbreaking, was conducted in rodents.

1
A new study points out that the popular medicine has the potential to improve the availability of stem cells used in transplants.
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

The scientists administered Sildenafil Citrate, an active ingredient of Viagra, to the animals, and a dose of Plerixafor medically used to direct stem cells from the blood to the bone marrow.

The organ is in charge of producing blood cells and, in people suffering from leukemia and lymphoma, it does not work as it should.

And the experiment worked – the availability of stem cells with the drug combination was 7.5 percent higher, twice as much as with Plerixafor alone.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Colombia's president announces a new cartel airstrike”

The research investigators believe that if these results are followed up by studies using humans, a new alternative to bone marrow transplants is possible, with the advantage of it being painless and safe.

“Doctors will be able to provide a unique treatment for conditions that currently have to be treated throughout a patient’s lifetime,” said scientist Camila Forsberg, who participated in the study.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.